Cerus (CERS) Competitors $1.41 -0.01 (-0.70%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. STAA, OSUR, UTMD, ANIK, WST, COO, ALGN, MMSI, HAE, and ICUIShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and ICU Medical (ICUI). These companies are all part of the "health care supplies" industry. Cerus vs. Its Competitors STAAR Surgical OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical STAAR Surgical (NASDAQ:STAA) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability. Is STAA or CERS more profitable? Cerus has a net margin of -10.23% compared to STAAR Surgical's net margin of -25.46%. STAAR Surgical's return on equity of -10.59% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets STAAR Surgical-25.46% -10.59% -8.32% Cerus -10.23%-34.81%-9.68% Do institutionals and insiders hold more shares of STAA or CERS? 96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by insiders. Comparatively, 3.4% of Cerus shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, STAA or CERS? STAAR Surgical has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTAAR Surgical$313.90M2.65-$20.21M-$1.44-11.65Cerus$180.27M1.50-$20.92M-$0.10-14.10 Does the media prefer STAA or CERS? In the previous week, STAAR Surgical had 3 more articles in the media than Cerus. MarketBeat recorded 5 mentions for STAAR Surgical and 2 mentions for Cerus. STAAR Surgical's average media sentiment score of 0.99 beat Cerus' score of 0.63 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend STAA or CERS? STAAR Surgical currently has a consensus price target of $24.63, suggesting a potential upside of 46.75%. Cerus has a consensus price target of $3.50, suggesting a potential upside of 148.23%. Given Cerus' stronger consensus rating and higher possible upside, analysts clearly believe Cerus is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STAAR Surgical 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, STAA or CERS? STAAR Surgical has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. SummarySTAAR Surgical beats Cerus on 9 of the 16 factors compared between the two stocks. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CERS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$269.54M$10.32B$5.46B$8.91BDividend YieldN/A2.10%5.36%4.15%P/E Ratio-14.1017.2826.4619.70Price / Sales1.5028.58404.54108.31Price / CashN/A23.5625.8827.49Price / Book4.553.657.925.42Net Income-$20.92M$233.36M$3.15B$248.34M7 Day Performance5.22%3.22%2.20%2.41%1 Month Performance13.71%3.03%4.39%4.80%1 Year Performance-19.89%-11.48%32.26%17.50% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.7479 of 5 stars$1.41-0.7%$3.50+148.2%-19.3%$269.54M$180.27M-14.10290STAASTAAR Surgical3.9895 of 5 stars$16.68+2.1%$24.63+47.6%-64.5%$826.16M$313.90M-11.581,211OSUROraSure Technologies2.4956 of 5 stars$3.03+1.0%$3.00-1.0%-29.3%$226.64M$161.63M-7.21840UTMDUtah Medical Products2.5803 of 5 stars$54.89+2.3%N/A-13.5%$178.28M$39.27M14.52180Positive NewsANIKAnika Therapeutics4.1056 of 5 stars$10.92+3.1%$20.00+83.2%-57.6%$156.59M$119.91M-2.81300Positive NewsWSTWest Pharmaceutical Services4.7269 of 5 stars$217.05+0.6%$332.50+53.2%-33.5%$15.60B$2.89B34.0710,600COOCooper Companies3.5094 of 5 stars$69.52+0.1%$99.70+43.4%-18.5%$13.89B$3.99B33.7516,000Trending NewsAnalyst UpgradeHigh Trading VolumeALGNAlign Technology4.8387 of 5 stars$183.42+0.9%$241.25+31.5%-21.9%$13.30B$4.00B33.4120,945News CoveragePositive NewsMMSIMerit Medical Systems4.3038 of 5 stars$92.32+0.4%$109.11+18.2%+8.8%$5.46B$1.36B45.267,400Positive NewsHAEHaemonetics4.8342 of 5 stars$72.15+1.5%$97.89+35.7%-10.6%$3.47B$1.36B21.803,023ICUIICU Medical4.5598 of 5 stars$128.07+0.3%$192.67+50.4%+11.0%$3.15B$2.38B-33.4415,000 Related Companies and Tools Related Companies STAA Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors COO Competitors ALGN Competitors MMSI Competitors HAE Competitors ICUI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
